MannKind 3Q 2026: Revenue $101.87M, EPS ($0.07) — 10-Q Summary

MannKind's third-quarter revenue rose 24% year over year, while it swung to a net loss from net income. Growth in commercial product sales and Tyvaso DPI royalties was partly offset by lower collaborations and services revenue; higher selling, general and administrative costs and other expense weig…